Invention Application
![PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO](/docs/US/2021-12-16/US20210387989A1/abs.jpg.600x600.jpg)
- Patent Title: PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO
-
Application No.: US17286018Application Date: 2019-10-21
-
Publication No.: US20210387989A1Publication Date: 2021-12-16
- Inventor: Brian Matthew SAMAS , Yong TAO , Douglas James Critcher , David Sydney Bernard Daniels , Kevin Paul Girard , Gregory Scott Goeken , Peter Robert Rose
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- International Application: PCT/IB2019/058940 WO 20191021
- Main IPC: C07D487/04
- IPC: C07D487/04
![PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO](/abs-image/US/2021/12/16/US20210387989A1/abs.jpg.150x150.jpg)
Abstract:
The present invention discloses a novel p-toluenesulfonic acid salt and a crystalline polymorphic Form 1 of said salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharmaceutical composition containing the same, as well as preparations and uses thereof. The present invention also discloses a novel phosphoric acid salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharmaceutical composition containing the same, as well as preparations and uses thereof.
Public/Granted literature
Information query
